3ro0 Citations

Terpyridine platinum(II) complexes inhibit cysteine proteases by binding to active-site cysteine.

J Biomol Struct Dyn 29 267-82 (2011)
Related entries: 3rnz, 3ro1

Cited: 3 times
EuropePMC logo PMID: 21875148

Abstract

Platinum(II) complexes have been demonstrated to form covalent bonds with sulfur-donating ligands (in glutathione, metallothionein and other sulfur-containing biomolecules) or coordination bonds with nitrogen-donating ligands (such as histidine and guanine). To investigate how these compounds interact with cysteine proteases, we chose terpyridine platinum(II) (TP-Pt(II)) complexes as a model system. By using X-ray crystallography, we demonstrated that TP-Pt(II) formed a covalent bond with the catalytic cysteine residue in pyroglutamyl peptidase I. Moreover, by using MALDI (matrix-assisted laser desorption/ionization) and TOF-TOF (time of flight) mass spectrometry, we elucidated that the TP-Pt(II) complex formed a covalent bond with the active-site cysteine residue in two other types of cysteine protease. Taken together, the results unequivocally showed that TP-Pt(II) complexes can selectively bind to the active site of most cysteine proteases. Our findings here can be useful in the design of new anti-cancer, anti-parasite or anti-virus platinum(II) compounds.

Reviews citing this publication (2)

  1. Pt-based drugs: the spotlight will be on proteins. Pinato O, Musetti C, Sissi C. Metallomics 6 380-395 (2014)
  2. A Structural Chemistry Perspective on the Antimalarial Properties of Thiosemicarbazone Metal Complexes. Summers KL. Mini Rev Med Chem 19 569-590 (2019)

Articles citing this publication (1)

  1. Labile Pd-sulphur and Pt-sulphur bonds in organometallic palladium and platinum complexes [(COD)M(alkyl)(S-ligand)]n+-A speciation study. Lingen V, Lüning A, Krest A, Deacon GB, Schur J, Ott I, Pantenburg I, Meyer G, Klein A. J Inorg Biochem 165 119-127 (2016)